C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

All articles by C. Andrew Kistler, MD, PharmD

COVID19

COVID-19 and IBD: Impact of Disease State and Biologics

C. Andrew Kistler, MD, PharmD

May 25, 2021

In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.

HIV/AIDS

HIV and Inflammatory Bowel Disease: A Unique Patient Population

C. Andrew Kistler, MD, PharmD

April 23, 2021

The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells.

Next post in HIV/AIDS

C. Andrew Kistler, MD, PharmD

All articles by C. Andrew Kistler, MD, PharmD

COVID-19 and IBD: Impact of Disease State and Biologics

HIV and Inflammatory Bowel Disease: A Unique Patient Population

Untreated Genital Tract Inflammation Plays Role in HIV Transmission